BARBUI, Corrado
 Distribuzione geografica
Continente #
EU - Europa 23.108
NA - Nord America 21.401
AS - Asia 14.830
SA - Sud America 2.565
AF - Africa 365
OC - Oceania 95
Continente sconosciuto - Info sul continente non disponibili 16
Totale 62.380
Nazione #
US - Stati Uniti d'America 20.890
RU - Federazione Russa 8.291
SG - Singapore 6.646
GB - Regno Unito 6.173
CN - Cina 4.167
BR - Brasile 2.117
IT - Italia 1.931
HK - Hong Kong 1.525
FR - Francia 1.439
DE - Germania 1.373
IE - Irlanda 1.085
VN - Vietnam 946
FI - Finlandia 927
SE - Svezia 899
KR - Corea 455
UA - Ucraina 364
CA - Canada 361
ID - Indonesia 192
TR - Turchia 172
AR - Argentina 162
IN - India 143
NL - Olanda 123
AT - Austria 95
BD - Bangladesh 91
JP - Giappone 87
ES - Italia 83
MX - Messico 82
ZA - Sudafrica 82
AU - Australia 80
EC - Ecuador 79
PL - Polonia 72
BE - Belgio 61
BJ - Benin 58
TG - Togo 55
IQ - Iraq 51
PE - Perù 45
MA - Marocco 40
VE - Venezuela 40
CO - Colombia 37
PK - Pakistan 36
UZ - Uzbekistan 33
IL - Israele 32
KE - Kenya 29
MY - Malesia 28
CL - Cile 26
EG - Egitto 24
UY - Uruguay 24
PY - Paraguay 23
JO - Giordania 20
PH - Filippine 20
RO - Romania 20
AE - Emirati Arabi Uniti 19
AZ - Azerbaigian 19
HU - Ungheria 17
IR - Iran 17
LT - Lituania 17
CZ - Repubblica Ceca 15
TN - Tunisia 15
EU - Europa 14
SA - Arabia Saudita 14
TH - Thailandia 14
CH - Svizzera 13
OM - Oman 12
GR - Grecia 11
NZ - Nuova Zelanda 11
PT - Portogallo 11
TW - Taiwan 11
BG - Bulgaria 10
BY - Bielorussia 10
JM - Giamaica 10
NP - Nepal 10
PS - Palestinian Territory 10
BO - Bolivia 9
KZ - Kazakistan 9
PA - Panama 9
SN - Senegal 9
SK - Slovacchia (Repubblica Slovacca) 8
DK - Danimarca 7
DO - Repubblica Dominicana 7
HN - Honduras 7
AL - Albania 6
CR - Costa Rica 6
LB - Libano 6
RS - Serbia 6
SI - Slovenia 6
DZ - Algeria 5
EE - Estonia 5
ET - Etiopia 5
GT - Guatemala 5
KG - Kirghizistan 5
LA - Repubblica Popolare Democratica del Laos 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BN - Brunei Darussalam 4
BW - Botswana 4
BZ - Belize 4
CD - Congo 4
CG - Congo 4
HR - Croazia 4
Totale 62.276
Città #
Southend 5.506
Singapore 3.055
Jacksonville 2.744
Moscow 2.492
Dallas 2.300
Chandler 2.239
Woodbridge 1.651
Hong Kong 1.446
Ashburn 1.387
Houston 1.178
Ann Arbor 1.065
Dublin 1.050
Beijing 700
Wilmington 529
Lawrence 504
Verona 503
Princeton 501
The Dalles 454
New York 403
Los Angeles 351
Nanjing 305
Jinan 297
Ho Chi Minh City 288
Munich 277
Buffalo 276
Shenyang 239
Sindelfingen 212
Redondo Beach 200
Milan 199
Helsinki 191
São Paulo 181
Hebei 176
Tianjin 150
Hanoi 144
Montréal 137
Columbus 131
London 131
Mcallen 131
Dong Ket 130
Boardman 124
Santa Clara 121
Jakarta 115
Changsha 114
Nanchang 113
Haikou 109
Council Bluffs 106
Ningbo 96
Dearborn 90
Rome 90
Guangzhou 87
Lappeenranta 87
Hangzhou 84
Zhengzhou 83
Seattle 82
Washington 82
Toronto 80
Chicago 77
Jiaxing 75
San Francisco 74
Norwalk 72
Tokyo 71
Nuremberg 69
Montreal 68
Redwood City 68
Rio de Janeiro 66
Taizhou 66
Taiyuan 59
Cotonou 58
Amsterdam 55
Belo Horizonte 55
Lomé 55
Warsaw 55
Lanzhou 53
Turku 52
Brussels 51
Vienna 51
Frankfurt am Main 49
Johannesburg 49
Bologna 47
Brooklyn 46
Fairfield 42
Kent 42
Curitiba 40
Redmond 40
Stockholm 39
Brasília 38
Istanbul 38
Atlanta 37
Düsseldorf 35
Mexico City 34
Fuzhou 33
Porto Alegre 33
Haiphong 32
Manchester 32
Poplar 32
Denver 31
Orem 31
Berlin 30
Boston 30
Falkenstein 28
Totale 37.654
Nome #
Forty years without mental hospitals in Italy 629
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 521
WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: a systematic review of evidence from low and middle-income countries 491
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 442
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 383
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 280
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 234
Il trattamento farmacologico degli attacchi di panico in medicina generale 219
Cerebral atrophy and white matter disruption in chronic schizophrenia 218
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 218
Assessment of cerebral blood volume in schizophrenia: a magnetic resonance imaging study 209
A Methodology for Adapting the WHO Evidence-Based Self-Help+ Intervention for Stress Management via Chatbot 207
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications 207
Access to and use of psychiatric services by migrants resettled in Northern Italy 206
Psychological treatments versus treatment as usual for obsessive compulsive disorder 205
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 199
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 198
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD 197
Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis 194
Psychological and psychosomatic symptoms of second victims of adverse events: a systematic review and meta-analysis 192
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 189
Clinical interventions for treatment non-adherence in psychosis: meta-analysis 189
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Razionale dello studio e metodologia 187
A practical framework for academics to implement public engagement interventions and measure their impact 185
Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction? 183
A simple approach to manage dosages in drug-epidemiology research 183
A New Approach to Psychiatric Drug Approval in Europe 182
Assessing risk of bias in randomized controlled trials 180
Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. 179
Access to mental health services and psychotropic drug use in refugees and asylum seekers hosted in high-income countries 179
Antidepressants and benzodiazepines for panic disorder in adults 178
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 177
Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. 177
Ricostruzione tridimensionale della volumetria cerebrale nella schizofrenia 176
"Wish bias" in antidepressant drug trials? 172
Dealing with adverse events: a meta-analysis on second victims' coping strategies 172
Allocation concealment and blinding in clinical trials 170
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 168
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 168
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 168
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 167
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 167
Predicting costs of mental health care: a critical literature review 166
What is the WHO essential medicines list? 165
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 165
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 165
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 164
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 162
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 162
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 162
Antidepressive Monotherapie 161
Rigour of development of clinical practice guidelines for the pharmacological treatment of bipolar disorder: systematic review 161
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 159
Guideline implementation strategies for specialist mental healthcare. 157
Antipsychotic drug exposure and risk of myocardial infarction 157
A cross-sectional audit of benzodiazepine use among general practice patients. 157
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 157
First-generation antipsychotics and QTc: any role for mediating variables? 156
Agomelatine and the brave old world of narrative-based medicine 155
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 154
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 154
Association of traumatic events with levels of psychological distress and depressive symptoms in male asylum seekers and refugees resettled in Italy 154
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 153
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 152
Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries 152
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Modalità di arruolamento dei soggetti nel centro di Verona e tipo di intervento 151
Antidepressants for the treatment of depression in people with cancer 151
A systematic review of cognitive effects of exercise in depression 151
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence 151
Amitriptyline versus other tricyclic drugs and selectivev serotonine reuptake inhibitors (SSRIs) for depression [Protocoll] 148
Efficacy of physical activity interventions on psychological outcomes in refugee, asylum seeker and migrant populations: a systematic review and meta-analysis 148
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 146
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 146
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 145
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials 145
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis 144
Antidepressant and antipsychotic drug prescribing in general population in Lombardy (in Italian) 143
Authors' reply to Magrini and colleagues 143
Azapirones versus placebo for panic disorder in adults 143
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies 143
Implementation of treatment guidelines for specialist mental health care 143
A Chat-Bot Based Version of the WHO-validated Intervention Self-Help+ for Stress Management in Breast Cancer Patients: Protocol for a Pilot Feasibility Study 142
Are all antidepressants really the same? The case of fluoxetine: a systematic review 142
Sertraline versus other antidepressive agents for depression 142
Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review 142
Behavioural activation therapy for depression in adults with non-communicable diseases 142
Access and use of psychotropic medicines in low-resource settings 141
Citalopram versus other anti-depressive agents for depression 140
Citalopram versus other anti-depressive agents for depression 140
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 139
Associazione tra TCA e SSRI nella depressione resistente 137
Off-label and non-classical prescriptions of antipsychotic agents in ordinary inpatient practice 137
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 137
Beneficial and harmful consequences of prepartum and postpartum antidepressant exposure 137
Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study 137
Identification and management of depression in primary care settings. A meta-review of evidence 136
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 136
Randomized trials published in Chinese or Western journals: comparative empirical analysis 136
Benzodiazepines and risk of dementia: true association or reverse causation? 136
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 136
Totale 18.171
Categoria #
all - tutte 218.299
article - articoli 210.322
book - libri 1.125
conference - conferenze 1.370
curatela - curatele 0
other - altro 2.042
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.440
Totale 436.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.958 0 0 0 0 0 463 68 313 288 146 410 270
2021/20223.270 184 725 57 154 249 64 39 221 134 106 340 997
2022/20237.161 602 496 801 1.178 690 1.566 102 479 849 88 189 121
2023/20244.040 209 367 319 448 529 576 205 260 61 180 502 384
2024/202511.203 704 714 557 1.746 589 416 636 585 1.709 831 733 1.983
2025/202619.315 2.289 1.710 2.567 4.447 7.133 1.169 0 0 0 0 0 0
Totale 62.896